Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

Sylvester, Richard; Brausi, Maurizio; Kirkels, Wim; Hoeltl, Wolfgang; Da Silva, Fernando; Powell, Philip; Prescott, Stephen; Kirkali, Ziya; van de Beek, Cees; Gorlia, Thierry; de Reijke, Theo

doi:10.1016/j.eururo.2009.12.024

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

Copy For Citation

Sylvester R. J., Brausi M. A., Kirkels W. J., Hoeltl W., Da Silva F. C., Powell P. H., ...More

EUROPEAN UROLOGY, vol.57, no.5, pp.766-773, 2010 (SCI-Expanded)

Publication Type: Article / Article
Volume: 57 Issue: 5
Publication Date: 2010
Doi Number: 10.1016/j.eururo.2009.12.024
Journal Name: EUROPEAN UROLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.766-773
Keywords: Bacillus Calmette-Guerin, Epirubicin, Instillation therapy, Isoniazid, Non-muscle-invasive bladder cancer, Randomized clinical trial, Urothelial carcinoma of the bladder, MITOMYCIN-C, CLINICAL-TRIALS, EUROPEAN ORGANIZATION, FORMAL METAANALYSIS, III TRIAL, CANCER, CHEMOTHERAPY, PROGRESSION, RECURRENCE
Dokuz Eylül University Affiliated: Yes

Abstract

Background: Intravesical chemotherapy and bacillus Calmette-Guerin (BCG) reduce the recurrence rate in patients with stage Ta T1 urothelial bladder cancer; however, the benefit of BCG relative to chemotherapy for long-term end points is controversial, especially in intermediate-risk patients.